Nombre del producto:4-(((Benzyloxy)carbonyl)amino)benzoic acid

IUPAC Name:4-{[(benzyloxy)carbonyl]amino}benzoic acid

CAS:5330-71-2
Fórmula molecular:C15H13NO4
Pureza:95%
Número de catálogo:CM322678
Peso molecular:271.27

Unidad de embalaje Stock disponible Precio($) Cantidad
CM322678-10g 3-4 Weeks ƴdžƚ
CM322678-25g 3-4 Weeks ŪƴŸ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :5330-71-2
Fórmula molecular:C15H13NO4
Punto de fusión:-
Código de sonrisas:O=C(O)C1=CC=C(NC(OCC2=CC=CC=C2)=O)C=C1
Densidad:
Número de catálogo:CM322678
Peso molecular:271.27
Punto de ebullición:
Nº Mdl:MFCD00610465
Almacenamiento:

Column Infos

Mitapivat
Jan. 03 2024, Agios announces Phase 3 ENERGIZE study of PYRUKYND (Mitapivat) met primary endpoint and both key secondary endpoints in adults with non-transfusion-dependent(NTD) alpha- or beta-thalassemia. The positive data showed Mitapivat’s potential to become the first oral therapy approved for NTD thalassemia.
Mitapivat is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the US, and for the treatment of PK deficiency in adult patients in the EU. By activating and stabilizing mutant pyruvate kinase, Mitapivat targets the underlying enzymatic defect that causes chronic hemolysis and ineffective erythropoiesis in order to restore enzyme activity.

Related Products